A detailed history of Weaver C. Barksdale & Associates, Inc. transactions in Johnson & Johnson stock. As of the latest transaction made, Weaver C. Barksdale & Associates, Inc. holds 7,628 shares of JNJ stock, worth $1.17 Million. This represents 1.12% of its overall portfolio holdings.

Number of Shares
7,628
Previous 8,033 5.04%
Holding current value
$1.17 Million
Previous $1.17 Million 5.28%
% of portfolio
1.12%
Previous 1.12%

Shares

14 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

SELL
$145.48 - $167.38 $58,919 - $67,788
-405 Reduced 5.04%
7,628 $1.24 Million
Q2 2024

Aug 12, 2024

SELL
$144.38 - $157.78 $26,854 - $29,347
-186 Reduced 2.26%
8,033 $1.17 Million
Q1 2024

May 14, 2024

SELL
$155.22 - $162.74 $13,504 - $14,158
-87 Reduced 1.05%
8,219 $1.3 Million
Q4 2023

Feb 13, 2024

SELL
$145.6 - $158.88 $332,696 - $363,040
-2,285 Reduced 21.57%
8,306 $1.3 Million
Q3 2023

Nov 14, 2023

BUY
$155.75 - $174.48 $86,441 - $96,836
555 Added 5.53%
10,591 $1.65 Million
Q2 2023

Aug 14, 2023

SELL
$154.35 - $166.11 $114,219 - $122,921
-740 Reduced 6.87%
10,036 $1.66 Million
Q1 2023

May 11, 2023

BUY
$151.05 - $180.26 $241,075 - $287,694
1,596 Added 17.39%
10,776 $1.67 Million
Q4 2022

Feb 14, 2023

BUY
$160.2 - $179.79 $41,491 - $46,565
259 Added 2.9%
9,180 $1.62 Million
Q3 2022

Nov 14, 2022

SELL
$161.33 - $179.52 $56,949 - $63,370
-353 Reduced 3.81%
8,921 $1.46 Million
Q2 2022

Aug 11, 2022

BUY
$168.19 - $186.01 $14,296 - $15,810
85 Added 0.93%
9,274 $1.65 Million
Q1 2022

May 16, 2022

BUY
$158.14 - $179.59 $20,241 - $22,987
128 Added 1.41%
9,189 $1.63 Million
Q4 2021

Feb 14, 2022

SELL
$155.93 - $173.01 $365,499 - $405,535
-2,344 Reduced 20.55%
9,061 $1.55 Million
Q4 2017

Jan 10, 2018

SELL
$131.22 - $143.62 $20,076 - $21,973
-153 Reduced 1.32%
11,405 $1.59 Million
Q3 2017

Oct 12, 2017

BUY
$129.47 - $135.38 $1.5 Million - $1.56 Million
11,558
11,558 $1.5 Million

Others Institutions Holding JNJ

About JOHNSON & JOHNSON


  • Ticker JNJ
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,614,479,872
  • Market Cap $401B
  • Description
  • Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide. The company's Consumer Health segment offers baby care products under the JOHNSON'S and AVEENO Baby brands; oral care products under the LISTERINE brand; skin health/beauty products under the...
More about JNJ
Track This Portfolio

Track Weaver C. Barksdale & Associates, Inc. Portfolio

Follow Weaver C. Barksdale & Associates, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Weaver C. Barksdale & Associates, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Weaver C. Barksdale & Associates, Inc. with notifications on news.